
Overview
Ceva Animal Health Polska is the Polish branch of the international Ceva group, active in animal health. The company markets products under the ADAPTIL brand and has taken over the product range of Merial. It announces new products from its ADAPTIL brand portfolio.
Financials
Revenue history (in m)
From the notes
| Profit allocation | Dividend and reserves | |
| Capital expenditure | $219,316 | |
| Planned capital expenditure (next year) | $44,199 | |
| Foreign sales | 6.8% of revenue ($3,517,614) | |
| Revenue structure | Sprzedaż towarów | |
| Management board pay | $225,921 |
Filing timeliness
6 of 6 financial statements were filed late (the longest delay 375 days for 2021). All were audited by a statutory auditor.
- 202517/11/2026
- 202417/12/2025
- 202304/11/2024
- 202217/10/2023
- 202125/07/2023
- 202018/08/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
News
Industry
Offer
- Veterinary preparations
- Poultry products
- Cattle products
- Pig products
- Companion animal products
- Dog and cat parasite products
Websites
The company has 32 websites, including 30 versions for foreign markets (e.g. Germany, United Kingdom, United States). The sites are available in: English, French, Dutch, Afrikaans, Romanian and 1 more. The sites also target these markets: Ireland.
Job offers
The company has its own careers page: ceva.pl/Kariera/Oferty-pracy-w-Polsce.
Authorized Representatives
Manner of representation
In the case of a multi-member management board, each member of the management board is authorised to represent the company externally, to make declarations and to sign documents on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Ceva Sante Animale S.A. | 500 | $2,360,615.88 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2007-01-01.
69 1600 1462 1808 5793 5000 0001
58 1600 1462 1808 5793 5000 0005
42 1600 1462 1808 5793 5000 0002
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $51,208$51,208 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $32,296$32,296 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $24,506$24,506 | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Reckitt Benckiser (Poland) S.A. | $148,551,741.42 | akcjonariuszerb.pl | ||
| Zoetis Polska sp. z o.o. | $112,174,378.00 | zoetis.com | ||
| Intervet sp. z o.o. | $93,722,514.35 | msd-animal-health.pl | ||
| Magnapharm Poland sp. z o.o. | $90,512,785.67 | magnapharm.pl | ||
| Ravet sp. z o.o. | $42,881,267.30 | ravet.pl | ||
| Vantage Trading sp. z o.o. | $24,835,003.93 | vantages.pl | ||
| New Approach sp. z o.o. | $22,884,976.86 | newapproach.pl | ||
| Medyk-Lek Panek sp. z o.o. sp. k. | $20,167,374.20 | medyklek.pl | ||
| Scanvet Poland sp. z o.o. | $10,081,778.54 | scanvet.pl | ||
| Animal-Pro sp. z o.o. | $8,346,539.17 | animal-pro.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-11-17 | Address change (Okrzei 1a, 03-715, Warszawa → Ul. Domaniewska 44, 02-672, Warszawa) | |
| 2018-02-06 | PKD change (Removed: 24, 24.4, 73.10.B, 73.10.D, 74.40.Z; Added: 74.20.Z) | |
| 2009-10-19 | Share capital increase (50,000.00 PLN → 8,739,000.00 PLN) | |
| 2007-03-01 | Address change (Rejtana 17/5, 02-516, Warszawa → Okrzei 1a, 03-715, Warszawa) | |
| 2005-12-23 | Share capital increase (25,000.00 PLN → 50,000.00 PLN) |
FAQ
Last updated: 2026-11-17
